Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/rheumatology/keae421 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Highlights from the breakout session: outcome predictors in small, large and variable vessel vasculitis.
Rheumatology (Oxford)
March 2025
Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Highlights from the breakout session: novel biomarkers of clinical interest for vasculitis.
Rheumatology (Oxford)
March 2025
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Highlights from the breakout session: optimising new treatments.
Rheumatology (Oxford)
March 2025
Vasculitis and Lupus Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
This session presented emerging realworld evidence on novel glucocorticoid (GC) sparing therapies for ANCA-associated vasculitis (AAV). It covered the first-in-class oral C5a receptor antagonist avacopan for severe granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), and antiinterleukin-5 therapies in the management of eosinophilic granulomatosis with polyangiitis (EGPA). Avacopan was approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of AAV in 2021, following the phase 3 ADVOCAT E trial comparing oral avacopan to an oral GC taper for GPA and MPA.
View Article and Find Full Text PDFHighlights from the breakout session: other forms of vasculitis.
Rheumatology (Oxford)
March 2025
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
The session on other forms of vasculitis included a masterful review on IgG4-related disease (IgG4-RD) following which two research studies evaluating therapeutic agents and one study on histopathologic findings of IgG4-RD were presented. Peyronel F., et al.
View Article and Find Full Text PDFHighlights from the breakout session: advances in treatment II.
Rheumatology (Oxford)
March 2025
Department of Nephrology, Fundacio Puigvert and Autónoma de Barcelona University, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!